GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Scaled Net Operating Assets

OncoSec Medical (FRA:ONMA) Scaled Net Operating Assets : -0.36 (As of Jan. 2023)


View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoSec Medical's operating assets for the quarter that ended in Jan. 2023 was €4.81 Mil. OncoSec Medical's operating liabilities for the quarter that ended in Jan. 2023 was €10.11 Mil. OncoSec Medical's Total Assets for the quarter that ended in Oct. 2022 was €14.66 Mil. Therefore, OncoSec Medical's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2023 was -0.36.


OncoSec Medical Scaled Net Operating Assets Historical Data

The historical data trend for OncoSec Medical's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Scaled Net Operating Assets Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.26 -0.03 0.04 -0.02 -

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - - -0.07 -0.36

Competitive Comparison of OncoSec Medical's Scaled Net Operating Assets

For the Biotechnology subindustry, OncoSec Medical's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OncoSec Medical's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoSec Medical's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where OncoSec Medical's Scaled Net Operating Assets falls into.



OncoSec Medical Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

OncoSec Medical's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2022 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jul. 2022 )
=(Operating Assets (A: Jul. 2022 )-Operating Liabilities (A: Jul. 2022 ))/Total Assets (A: Jul. 2021 )
=(9.415-9.422)/47.609
=-0.00

where

Operating Assets(A: Jul. 2022 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=21.506 - 12.091
=9.415

Operating Liabilities(A: Jul. 2022 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=15.492 - 4.057 - 2.013
=9.422

OncoSec Medical's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jan. 2023 )
=(Operating Assets (Q: Jan. 2023 )-Operating Liabilities (Q: Jan. 2023 ))/Total Assets (Q: Oct. 2022 )
=(4.814-10.108)/14.656
=-0.36

where

Operating Assets(Q: Jan. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=8.232 - 3.418
=4.814

Operating Liabilities(Q: Jan. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=13.324 - 1.974 - 1.242
=10.108

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OncoSec Medical Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of OncoSec Medical's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoSec Medical Business Description

Traded in Other Exchanges
N/A
Address
24 North Main Street, Pennington, NJ, USA, 08534
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical Headlines

No Headlines